|
|
|
|
Molecular Pharmacology, Vol 13, 352-361, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology, University of Wisconsin-Madison, Madison, Wisconsin 53706
Association and dissociation rates of cardiac aglycone-(Na+ + K+-ATPase complexes
formed in the presence of magnesium and inorganic phosphate were examined by assay
of the phosphorylated protein formed in the presence of [
-32P]ATP, which is influenced
by the amount of bound aglycone. Association and dissociation followed pseudo-first-order and first-order rate kinetics, respectively. The dissociation rate constants of four
cardiac aglycones-digitoxigenin, digoxigenin, strophanthidin, and ouabagenin-were
all the same (0.28 min-1 at 25° and 0.63 min-1 at 30°), but their pseudo-first-order
association rate constants (ka' varied. Both Mg2+ and P1 gave linear relationships
against ka' in double-reciprocal plots over a wide range of concentrations, and the effects
of both ligands were identical. The four cardiac aglycones showed the same maximum
association rates with increasing drug concentration. These results suggest that the
binding of ligands (magnesium and phosphate) results in activation of the enzyme to
bind the cardiac aglycone, but that dissociation of ligands from the cardiac aglyconeenzyme complex precedes the release of cardiac aglycone.
Note:
ACKNOWLEDGMENTS
We thank Dr. Lowell E. Hokin for his kind help
with the manuscript, and Mrs. Mary Lochner, for
preparation of beef microsomes.
This article has been cited by other articles:
![]() |
P. Artigas and D. C. Gadsby Large Diameter of Palytoxin-induced Na/K Pump Channels and Modulation of Palytoxin Interaction by Na/K Pump Ligands J. Gen. Physiol., March 29, 2004; 123(4): 357 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ferrari, L. Torielli, M. Ferrandi, G. Padoani, L. Duzzi, M. Florio, F. Conti, P. Melloni, L. Vesci, N. Corsico, et al. PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 83 - 94. [Abstract] [Full Text] |
||||